Skip to main content
HHS Author Manuscripts logoLink to HHS Author Manuscripts
. Author manuscript; available in PMC: 2022 Jul 1.
Published in final edited form as: J Occup Environ Med. 2022 Jan 1;64(1):39–45. doi: 10.1097/JOM.0000000000002328

Prevalence of Self-Reported Prescription Opioid Use and Illicit Drug Use Among U.S. Adults

NHANES 2005–2016

Ja K Gu 1, Penelope Allison 2, Alexis Grimes Trotter 3,4, Luenda E Charles 5, Claudia C Ma 6,7, Matthew Groenewold 8, Michael E Andrew 9, Sara E Luckhaupt 10
PMCID: PMC9136916  NIHMSID: NIHMS1800056  PMID: 34310540

Abstract

Objective:

To estimate the self-reported prevalence of prescription opioid use and illicit drug use in the United States.

Methods:

Self-reported prescription opioid use and illicit drug use (mostly nonopioid) were obtained for adults and adult workers (NHANES 2005–2016).

Results:

Prevalence (95% CI) of prescription opioid use was 6.5% (6.0–7.0) (adults) and 4.1% (3.7–4.5) (workers). Prevalence of illicit drug use was 9.5% (8.8–10.1) (adults) and 10.2% (9.4–11.1) (workers). Among occupations, prevalence of prescription opioid use was highest in personal care (6.5%; 4.1–10.4) and healthcare practitioners (5.9%; 3.8–9.0); for illicit drug use, construction/extraction (18.0%; 15.1–21.3) and food preparation (15.8%; 12.5–19.7).

Conclusion:

The prevalence of prescription opioid use was elevated among some occupations. Judicious prescription strategies and targeted interventions are both needed. The prevalence of illicit drug use among certain occupational groups suggests the need to ensure access to therapy.

Keywords: illicit drug use, industry, NHANES, occupation, prescription opioid use


For the past two decades, increasing overdoses involving opioids have adversely affected the United States (U.S.) population, resulting in an opioid overdose epidemic that was declared a National Public Health Emergency in the fall of 2017.1,2 Although the epidemic began with the over-prescribing of prescription opioids, overdose deaths from illicit drugs such as illicitly manufactured fentanyl, heroin, and cocaine has become epidemic as states have mandated the requirements of the prescription drug monitoring programs (PDMPs).1,3,4 The rate of opioid-involved overdose deaths increased five-fold, from 2.9 per 100,000 population in 1999 to 14.6 per 100,000 in 2018.5

Since work is an important aspect of life for the majority of U.S. adults, occupational factors could potentially influence opioid use. For example, a work-related injury or illness could be the proximate cause for an opioid prescription that eventually leads to opioid misuse, use disorder, other illicit drug use, and overdose. This suggests that occupations or industries with high injury or illness rates might have high rates of opioid use or misuse. A recent study conducted by the National Institute for Occupational Safety and Health (NIOSH) found that workers in construction, extraction, and health care practitioner occupations had the highest prevalence of opioid-involved deaths.6

Workers’ compensation studies have shown that 44% of all claims had at least one opioid prescribed; 45% of the claimants received an opioid prescription two or more years after the initial injury date.7 Long-term use of opioids and illicit drugs may increase the opportunity for the development of opioid use disorders.8 Moreover, other workers’ compensation studies have suggested that, among all occupational groups, construction workers have one of the highest rates of opioid dispensing.911 However, not all U.S. employers are covered by workers’ compensation programs and some occupational groups are more likely than others to experience events resulting in workers’ compensation claims. Therefore, studies of workers’ compensation data do not provide a comprehensive view of opioid use disorder among U.S. workers, although they offer a valuable viewpoint of opioid prescribing.

Researchers studying prescription opioid use also use nationally representative datasets such as the Medical Expenditure Panel Survey (MEPS) to provide a broader view of the opioid crisis, by examining the prescription opioid use among the U.S. working population. Such examination may be helpful in identifying and understanding the potential occupational antecedents of prescription opioid prescribing and associated risk factors. According to a study using MEPS data by Asfaw et al, there was a high prevalence of prescription opioid use (regardless of payer) among construction workers, which was consistent with worker overdose mortality and workers’ compensation studies.11,12

In this study, we look to broaden the scope of our understanding of the opioid crisis as it manifests among the working population by addressing gaps in our knowledge. We describe the prevalence of both legal prescription opioid use and illicit drug use, mostly drugs other than opioids, among U.S. workers by demographic and lifestyle characteristics, industry, and occupation, and provide prevalence estimates with specific industry and occupation groups according to the most recent data available from the National Health and Nutrition Examination Survey (NHANES).

METHODS

Data Source and Study Population

Prescription opioid use and illicit drug use was assessed using data from the NHANES, which is developed and administered by the National Center for Health Statistics (NCHS) of the U.S. Centers for Disease Control and Prevention (CDC). The NHANES was created to assess the health and nutritional status of the U.S. population. Since 1999, the NHANES has been designed as a nationally representative cross-sectional survey conducted in 2-year cycles. Data are collected through in-person household interviews and physical examinations in specially designed and equipped mobile centers. As a multistage, stratified, complex, probability sample, NHANES oversamples persons of racial/ethnic minority subgroups (eg, non-Hispanic blacks, Hispanics, and non-Hispanic Asians), low-income persons, and older adults. Individuals therefore are assigned weights to account for their unequal sampling probability and nonresponse. Extensive details about the questionnaire, methodology, data, and documentation are available on the NHANES website https://wwwn.cdc.gov/nchs/nhanes/AnalyticGuidelines.aspx.

Analyses for this study are based on data collected from those aged 18 years or older during the six NHANES survey cycles during 2005 to 2016. The selection of cycles was determined by data availability. The data for prescription medication, illicit drug use, and characteristics are available in the 2005 to 2016 survey data, while coded industry and occupation data are only available from 2005 to 2014.

The total pooled NHANES sample size for 2005 to 2016 was 60,936, with varying response rate from 61% in 2015 to 2016 to 80% in 2005 to 2006. The sample for analysis of U.S. adults (aged 18 years or older) was 36,287. The sample for analysis of U.S. adult workers (aged 18 years and older who were “working at a job or business” or “with a job or business but not at work” during the week prior to their interview) was 19,858, after excluding 16,429 persons who did not have a job in the past week (eg, those who were unemployed, retired, or students). The sample for analysis of U.S. adult workers by industry and occupation groups was 16,421 in 2005 to 2014. Supplement Figure 1, http://links.lww.com/JOM/A971, shows the flowchart of inclusion and exclusion criteria of this study.

Prescription Opioid Use

Participants were asked by trained interviewers if they had taken any prescription medication during the month prior to the survey date. Those who responded “yes” were asked to show the interviewer the medication containers of all the products used. If no container was available, participants were asked to report the name of the medication.

All drug names entered by the interviewer were compared to the Multum Lexicon Drug Database, which is a comprehensive database of all prescription and some nonprescription drug products available in the U.S. drug market. The medications were coded using the Multum Lexicon Therapeutic Classification Scheme, a 3-level nested category system that assigns a therapeutic classification to each drug and each ingredient of the drug. Detailed information about the Multum Lexicon Drug Database is available at https://wwwn.cdc.gov/Nchs/Nhanes/1999-2000/RXQ_DRUG.htm. Codes used to identify prescription opioid use were: Level 1: 57 = central nervous system agents; Level 2: 58 = Analgesics; Level 3: 60 = narcotic analgesics, or 191 = narcotic analgesics combinations. Medications containing buprenorphine were excluded because they are used to treat use disorder.13

The duration of use was recorded for each prescription medication. Long-term opioid therapy was defined as medication taken for more than 90 days. To calculate the proportion of long-term use among those reporting any prescription opioid use, the following formula was used: the weighted number of persons who reported long-term opioid therapy over the weighted number of persons who reported prescription opioid use.

Illicit Drug Use

Adults were asked about use of drugs not prescribed by a doctor. Illicit drug use was defined as any use of marijuana or hashish, cocaine, heroin, or methamphetamine during the past 30 days or injection use of nonprescription drugs during the past 30 days. Participants aged 18 to 59 years were asked if they used marijuana, cocaine, heroin, methamphetamine, and needle injection drugs (cocaine, heroin, methamphetamine, steroids, and any other drugs) during the past 30 days. Participants aged 18 to 69 years were asked if they injected any nonprescription drugs during the past 30 days. This measure of nonprescription drug use does not include opioids specifically, and therefore cannot evaluate illicit opioid use, although a small amount of illicit opioid use may be captured as part of the “other” response to IV drug use in the past 30 days. The interview questions were self-administered using the Audio Computer-Assisted Self-Interviewing system at the Mobile Examination Center (MEC). No proxy respondents or translators were used in situations when the respondents could not self-report. Individuals with mental impairments or those with language barriers were not asked these questions.

Demographic, Lifestyle, and Job Characteristics

We obtained data from the NHANES questionnaire on age (18 to 29, 30 to 44, 45 to 59, 60+ years), gender (male, female), race and Hispanic origin (non-Hispanic white, non-Hispanic black, other race, and Hispanic), education (< high school, high school or equivalent, some college, and college degree or higher), smoking status (never, former, and current), type of employment (private companies, government, self-employed, unemployed, retired, and nonemployed), and work hours per week (<40 hours, 40 hours, and >40 hours). Alcohol consumption was categorized into three groups (none, moderate, and heavy) as defined by CDC (https://www.cdc.gov/alcohol/fact-sheets/alcohol-use.htm). Moderate drinking was defined as consuming up to 7 drinks of alcohol per week for women and up to 14 drinks for men. Consumption beyond these amounts was considered heavy drinking.

At the time of these analyses, the most recent data available from the NHANES occupational questionnaire was for 2005 to 2014. It was coded into occupation and industry groups based on 4-digit U.S. Census Bureau codes that are consistent with the Standard Occupational Classification (SOC) system and the North American Industry Classification System (NAICS). The public use data files provided 22 broad industry groups and 23 broad occupational groups. This study includes all groups, except for "Armed Forces."

Statistical Analysis

The NHANES data in the current analyses were combined into six 2-year cycles during 2005 to 2016 and were analyzed according to NHANES Analytic Guidelines 1999 to 2010 (https://www.cdc.gov/nchs/data/series/sr_02/sr02_161.pdf) and 2011–2016 (https://wwwn.cdc.gov/nchs/data/nhanes/2011-2012/analyticgui-delines/analytic_guidelines_11_16.pdf). To attain unbiased estimates, all analyses were weighted to account for the complex survey design and survey nonresponse using SAS-callable SUDAAN v11.0 software (Research Triangle Institute, Research Triangle Park, NC). In order to accurately represent the population of the U.S., all analyses were performed using the interview weight variable, which was divided by 6 to take into consideration the six 2-year cycles during 2005 to 2016. Standard errors were estimated using Taylor series linearization methods.

We assessed the prevalence of prescription opioid use and illicit drug use by demographic factors (age, gender, race/ethnicity, and education level), lifestyle habits (alcohol consumption and smoking status), and employment characteristics (type of employment and work hours per week) in 2005 to 2016 (Tables 1 and 2) and by industry and occupation groups in 2005 to 2014 (Tables 3 and 4). Differences in prevalence between categories within these groups were not tested for statistical significance. The prevalence estimates (%) were weighted and age-adjusted to the 2010 U.S. adult standard population for age groups: 18 to 29, 30 to 44, 45 to 59, 60+ years. The relative standard error (RSE) is defined by the standard error of the estimate divided by the estimate and then multiplied by 100. The point estimates of prevalence with the relative standard error larger than 30% were considered unreliable and were identified by a symbol (#) in the tables.

Table 1.

Temporal trends in the age-adjusted prevalence1 of prescription opioid and illicit drug use by characteristics among all US adults 2005–2016

Rx Opioid Use
Chronic Rx Opioid Use2
Illicit Drug Use3
N n Overall Prev. (95%CI) Slope4 (SE) p for trend4 n Prev. (95%CI)2 Slope4 (SE) p for trend4 n Prev. (95%CI) Slope4 (SE) p for trend4




US adults 36,287 2,345 6.5 (6.0, 7.0) −0.19 (0.11) 0.1608 1,668 63.9 (61.7, 66.1) 2.80 (0.83) 0.0280 3,088 9.5 (8.8, 10.1) 0.76 (0.14) 0.0056




Age
 18–29 8,037 231 3.6 (3.0, 4.2) −0.57 (0.07) 0.0011 64 29.3 (22.5, 37.3) 5.47 (2.95)# 0.1377# 1,421 19.0 (17.6, 20.5) 1.76 (0.38) 0.0096
 30–44 8,802 457 5.3 (4.6, 6.1) −0.40 (0.17) 0.0732 278 60.7 (56.4, 64.8) 3.87 (1.13) 0.0265 1,006 11.4 (10.3, 12.7) 0.38 (0.29) 0.2673
 45–59 8,118 661 8.2 (7.2, 9.2) −0.14 (0.22) 0.5608 514 78.8 (74.4, 82.7) 1.40 (0.92) 0.2045 656 8.3 (7.3, 9.4) 1.03 (0.28) 0.0220
 60+ 11,330 996 8.6 (7.8, 9.4) 0.12 (0.33) 0.7361 812 81.9 (78.3, 85.0) 1.87 (0.84) 0.0895 5 0.0 (0.1, 0.1)# n/a n/a
Gender
 Male 17,618 1,006 5.7 (5.1, 6.4) −0.21 (0.21) 0.3869 722 63.6 (59.4, 67.6) 1.68 (2.00) 0.4461 1,967 12.2 (11.4, 13.0) 0.69 (0.18) 0.0196
 Female 18,669 1,339 7.3 (6.7, 7.8) −0.09 (0.10) 0.4197 946 64.2 (60.7, 67.6) 3.61 (0.47) 0.0015 1,121 6.8 (6.2, 7.5) 0.72 (0.13) 0.0047
Race/Ethnicity
 White (NH) 15,162 1,266 7.1 (6.5, 7.8) −0.28 (0.13) 0.0901 939 65.1 (62.2, 67.8) 3.15 (1.14) 0.0502 1,357 10.0 (9.1, 10.9) 0.81 (0.29) 0.0490
 Black (NH) 7,910 499 6.5 (5.9, 7.2) 0.07 (0.27) 0.8070 346 60.9 (54.7, 66.8) 1.06 (0.68) 0.1888 929 12.7 (12.0, 13.5) 0.83 (0.32) 0.0622
 Hispanic 9,508 448 5.0 (4.4, 5.6) 0.11 (0.08) 0.2458 287 54.9 (49.9, 59.8) 3.00 (1.54) 0.1230 562 6.4 (5.7, 7.2) 0.63 (0.18) 0.0264
 Others (NH) 3,707 132 4.4 (3.4, 5.7) −0.07 (0.58)# 0.9138# 96 72.9 (63.4, 80.6) 2.53 (4.11) 0.5717 240 6.4 (5.3, 7.6) 0.67 (0.21) 0.0331#
Education level
 < High school 8,973 714 8.1 (7.1, 9.3) −0.24 (0.24) 0.3674 526 61.2 (57.4, 64.9) 1.94 (0.96) 0.1142 679 11.8 (10.6, 13.0) 0.70 (0.24) 0.0427
 High / GED 7,777 593 7.9 (7.0, 8.8) 0.08 (0.10) 0.4474 439 68.8 (62.9, 74.1) 5.44 (2.33) 0.0803 770 11.3 (10.2, 12.6) 0.79 (0.27) 0.0438
 Some college 9,783 705 7.5 (6.9, 8.2) 0.01 (0.14) 0.9294 504 65.2 (60.9, 69.2) 3.28 (0.74) 0.0115 989 10.6 (9.8, 11.5) 0.55 (0.22) 0.0672
 College degree 7,599 290 3.6 (3.1, 4.2) −0.49 (0.16) 0.0382 190 57.5 (51.1, 63.7) 0.14 (1.67) 0.9395 363 5.9 (4.8, 7.3) 0.64 (0.12) 0.0058
Alcohol consumption5
 None 12,290 841 6.6 (5.9, 7.4) −0.02 (0.14) 0.8732 631 69.5 (64.9, 73.8) 3.06 (1.39) 0.0932 468 4.6 (4.0, 5.2) 0.03 (0.13) 0.8454
 Moderate 10,343 522 5.0 (4.4, 5.6) −0.15 (0.17)# 0.4199# 307 52.9 (47.9, 57.9) 4.01 (0.93) 0.0127 1,585 13.5 (12.5, 14.5) 0.77 (0.45) 0.1646
 Heavy 2,381 133 5.4 (4.2, 6.9) −0.26 (0.34) 0.4858 98 68.5 (59.6, 76.5) 7.52 (1.47)# 0.0088# 637 24.3 (22.1, 26.6) 1.61 (0.36) 0.0113
Smoking status
 Never 19,379 870 4.5 (4.1, 5.0) −0.25 (0.12) 0.1000 583 58.7 (54.6, 62.6) 1.14 (1.04) 0.3355 859 4.4 (4.0, 4.9) 0.33 (0.07) 0.0109
 Former 8,192 685 7.7 (6.7, 8.8) −0.20 (0.18) 0.3231 527 64.0 (57.8, 69.8) 4.43 (1.18) 0.0200 449 11.0 (9.5, 12.8) 0.71 (0.72) 0.3811
 Current 7,194 752 10.7 (9.7, 11.9) 0.38 (0.36) 0.3581 550 69.8 (65.5, 73.8) 4.32 (0.81) 0.0060 1,627 21.1 (19.5, 22.7) 1.5 (0.25) 0.0037
Types of employment
 Private companies 14,915 520 4.2 (3.7, 4.8) −0.39 (0.18) 0.0936 256 52.3 (47.2, 57.3) 4.5 (1.0) 0.0115 1,588 9.2 (8.5, 10.0) 0.41 (0.17) 0.0728
 Government 2,848 121 4.6 (3.7, 5.8) 0.38 (0.14)# 0.0495# 79 64.3 (52.4, 74.6) 5.6 (3.1)# 0.1436# 156 5.1 (4.1, 6.4) 0.52 (0.58) 0.4231
 Self-employed 1,914 64 3.4 (2.5, 4.7) 0.61 (0.24)# 0.0617# 39 66.0 (51.5, 77.9) 0.6 (3.8)# 0.8711 186 11.6 (9.7, 13.9) 0.60 (0.74) 0.4619
 Unemployed 1,676 63 4.9 (3.3, 7.1) −0.94 (0.58)# 0.1789# 40 76.8 (67.4, 84.0) 6.4 (3.4)# 0.1571# 337 16.2 (14.2, 18.5) 0.95 (0.71) 0.2492
 Retired 6,641 568 4.9 (3.5, 7.0) 0.13 (0.57)# 0.8316# 467 65.9 (46.4, 81.1) 12.7 (1.2) 0.0004 20 6.5 (1.5, 23.8) 3.39 (0.98)# 0.0406#
 Not in the labor force6 8,081 1,007 14.4 (13.1, 15.8) −0.40 (0.13) 0.0409 786 70.3 (66.0, 74.3) 0.88 (1.8) 0.6544 780 9.7 (8.7, 10.8) 0.81 (0.29) 0.0492
1

The prevalence estimates (%) were weighted and age-adjusted to the 2010 U.S. adults standard population using six age groups: 18–29, 30–44, 45–59, 60+.

2

Chronic Rx opioid use means taking prescription opioid mediation more than 90 days. When calculating prevalence of chronic Rx opioid use, the denominator is the weighted number of Rx opioid use and the numerator is the weighted number of chronic Rx opioid use.

3

Illicit drugs are the non-prescription opioid drugs included Marijuana, hashish, cocaine, heroin, methamphetamine, or intravenous use of drugs (cocaine, heroin, methamphetamine, steroids, and any other drugs). Participants aged 18–59 years only were asked if they used marijuana, cocaine, heroin, methamphetamine, and needle injections drugs (cocaine, heroin, methamphetamine, steroids, and any other drugs) during the past 30 days. Participants aged 18–69 years were asked if they injected any non-prescription drugs during the past 30 days.

4

Slope and p-value for trend were from weighted linear regression from 2005 to 2016.

5

For men, moderate drinking was defined as 1–14 drinks/wk and heavy drinking 15+ drinks/wk. For women, moderate drinking was defined as 1–7 drinks/wk and heavy drinking 7+ drinks/wk.

6

Not in the labor force includes those who did not work due to taking care of family, going to school, unable to work for health reasons, disabled, and others.

#

The slope and p for trend are unreliable since prevalence in a survey cycle year is unreliable because the relative standard error of the estimate is larger than 30%.

Table 2.

Temporal trends in the age-adjusted prevalence1 of prescription opioid and illicit drug use by characteristics among US adult workers 2005–2016

Rx Opioid Use
Chronic Rx Opioid Use2
Illicit Drug Use3
N n Overall Prev. (95%CI) Slope4 (SE) p for trend4 n Prev. (95%CI)2 Slope4 (SE) p for trend4 n Prev. (95%CI) Slope4 (SE) p for trend4




US adult workers 19,858 706 4.1 (3.7, 4.5) −0.27 (0.12) 0.0892 374 54.4 (50.5, 58.2) 4.12 (0.61) 0.0025 1,949 10.2 (9.4, 11.1) 0.53 (0.13) 0.0165




Age
 18–29 5,096 149 3.5 (2.9 4.2) −0.68 (0.05) 0.0001 37 27.1 (18.8, 37.3) 5.27 (4.03)# 0.2611# 909 19.0 (17.3, 20.9) 1.94 (0.47) 0.0145
 30–44 6,501 224 3.7 (3.1, 4.4) −0.26 (0.13) 0.1235 115 52.8 (45.5, 59.9) 6.98 (1.09) 0.0031 671 10.8 (9.6, 12.1) 0.21 (0.36) 0.5978
 45–59 5,592 217 4.7 (3.9,5.6) −0.06 (0.26) 0.8224 142 70.1 (62.1, 77.0) 1.24 (1.99) 0.5654 368 7.1 (6.0, 8.3) 0.30 (0.29) 0.3662
 60+ 2,669 116 4.5 (3.6, 5.7) −0.27 (0.42)# 0.5613# 80 67.6 (54.4, 78.4) 9.39 (1.86)# 0.0072# 1 - - -
Gender
 Male 10,593 328 3.6 (3.1, 4.2) −0.43 (0.23) 0.1368 178 53.1 (46.1, 60.0) 3.78 (2.14) 0.1521 1,300 12.8 (11.7, 13.9) 0.44 (0.23) 0.1266
 Female 9,265 378 4.6 (4.0, 5.2) −0.11 (0.07) 0.1735 196 55.4 (50.2, 60.6) 5.09 (1.22) 0.0142 649 7.3 (6.5, 8.2) 0.59 (0.13) 0.0096
Race/Ethnicity
 White (NH) 7,919 398 4.7 (4.2, 5.3) −0.37 (0.16) 0.0760 222 55.4 (50.2, 60.5) 4.66 (0.68) 0.0023 907 11.1 (10.0, 12.2) 0.40 (0.20) 0.1128
 Black (NH) 4,195 141 3.4 (2.9, 4.1) 0.10 (0.11) 0.4421 74 50.3 (41.6, 59.1) 0.30 (3.83)# 0.9409# 514 12.5 (11.4, 13.6) 0.86 (0.47) 0.1373
 Hispanic 5,531 117 2.3 (1.9, 2.8) −0.10 (0.07) 0.2639 48 39.6 (30.0, 50.0) 4.49 (2.37)# 0.1307# 372 7.0 (6.1, 8.0) 0.80 (0.16) 0.0071
 Others (NH) 2,213 50 3.2 (2.1, 4.7) −0.16 (0.56)# 0.7823# 30 67.0 (54.3, 77.6) 5.61 (3.69)# 0.2263# 156 6.9 (5.5, 8.6) 1.04 (0.33)# 0.0331#
Education level
 < High school 3,745 119 4.1 (3.1, 5.4) −0.59 (0.19)# 0.0342# 63 47.9 (37.7, 58.3) 6.36 (3.06)# 0.0348# 351 11.8 (10.4, 13.4) 0.49 (0.26) 0.1361
 High / GED 4,115 175 4.7 (3.8, 5.7) −0.14 (0.21) 0.5354 102 61.4 (52.8, 69.3) 4.89 (3.30) 0.2119 495 12.3 (10.9, 13.8) 0.57 (0.32) 0.1481
 Some college 5,804 242 5.0 (4.3, 5.7) −0.22 (0.25) 0.4344 130 54.7 (47.7, 61.5) 4.48 (2.52) 0.1503 659 11.6 (10.6, 12.7) 0.40 (0.35) 0.3183
 College degree 5,180 147 2.9 (2.4, 3.6) −0.50 (0.15) 0.0269 77 49.9 (41.5, 58.3) 1.36 (1.99)# 0.5304# 303 7.0 (5.5, 8.8) 0.59 (0.21) 0.0519
Alcohol consumption5
 None 5,903 198 3.8 (3.2, 4.6) −0.17 (0.19) 0.4082 119 62.8 (55.8, 69.4) 2.42 (2.20) 0.3324 252 4.6 (3.9, 5.5) 0.02 (0.13) 0.9111
 Moderate 6,885 239 3.9 (3.2, 4.7) −0.08 (0.19) 0.7140 107 45.0 (37.1, 53.1) 5.29 (2.16) 0.0707 1,071 14.2 (12.9, 15.5) 0.49 (0.54) 0.4154
 Heavy 1,453 49 3.8 (2.6, 5.6) −0.23 (0.27)# 0.4425# 31 65.0 (49.6, 77.9) 6.26 (2.61)# 0.1386# 412 26.6 (23.5, 29.9) 1.18 (0.29) 0.0148
Smoking status
 Never 11,386 288 2.8 (2.4, 3.3) −0.32 (0.08) 0.0151 143 48.9 (42.3, 55.5) 0.51 (2.48) 0.8480 601 5.0 (4.5, 5.6) 0.32 (0.18) 0.1533
 Former 3,804 178 5.4 (4.3, 6.8) −0.52 (0.20) 0.0635 97 53.9 (45.7, 61.9) 6.17 (2.99) 0.1083 327 12.9 (10.8, 15.4) 0.77 (0.93) 0.4526
 Current 3,943 221 6.3 (5.4, 7.3) −0.05 (0.29) 0.8729 133 62.4 (53.3, 70.8) 6.95 (2.46) 0.0474 951 22.6 (20.7, 24.5) 1.13 (0.30) 0.0198
Work hours
 <40 hours 6,376 244 4.2 (3.5, 5.0) −0.45 (0.18) 0.0661 129 54.5 (47.4, 61.5) 0.71 (2.95) 0.8225 752 11.5 (10.6, 12.5) 0.69 (0.53) 0.2619
 =40 hours 6,005 173 3.8 (3.1, 4.6) 0.45 (0.13)# 0.1287# 104 61.5 (53.0, 69.2) 6.29 (1.31)# 0.0086# 538 10.2 (8.9, 11.7) 0.40 (0.28) 0.2302
 >40 hours 6,747 225 3.7 (3.1, 44) −0.28 (0.14) 0.1144 118 53.6 (45.8, 61.3) 4.22 (1.82) 0.0818 590 9.1 (8.1, 10.2) 0.53 (0.16) 0.0293
1

The prevalence estimates (%) were weighted and Prevalence estimates were age adjusted to the 2010 U.S. adult workers standard population by Bureau of Labor Statistics, using five age groups: 18–34, 35–44, 45–54, 55–64, 65+ years.

2

Chronic Rx opioid use means taking prescription opioid mediation more than 90 days. When calculating prevalence of chronic Rx opioid use, the denominator is the weighted number of Rx opioid use and the numerator is the weighted number of chronic Rx opioid use.

3

Illicit drugs are the non-prescription opioid drugs included Marijuana, hashish, cocaine, heroin, methamphetamine, or intravenous use of drugs (cocaine, heroin, methamphetamine, steroids, and any other drugs). Participants aged 18–59 years only were asked if they used marijuana, cocaine, heroin, methamphetamine, and needle injections drugs (cocaine, heroin, methamphetamine, steroids, and any other drugs) during the past 30 days. Participants aged 18–69 years were asked if they injected any non-prescription drugs during the past 30 days.

4

Slope and p-value for trend were from weighted linear regression.

5

For men, moderate drinking was defined as 1–14 drinks/wk and heavy drinking 15+ drinks/wk. For women, moderate drinking was defined as 1–7 drinks/wk and heavy drinking 7+ drinks/wk.

#

The slope and p for trend are unreliable since prevalence in a survey cycle year is unreliable because the sample in the denominator in each is less than 30 or the relative standard error of the estimate is larger than 30%.

Table 3.

Age-adjusted prevalence1 of prescription opioids and illicit drug use among US adult workers, by industry groups: 2005–2014

Rx opioid use
Illicit drug use
Sample No. of Rx opioid Prev.1 (95%CI) No. of illicit drug Prev.1 (95%CI)



All 16,421 615 4.4 (3.9, 4.9) 1,550 9.7 (9.0, 10.4)



Agriculture, forestry, fishing, and hunting 252 5 2.5 (0.9, 6.8)# 9 3.8 (1.6, 8.4)#
Mining 92 4 7.4 (2.9, 17.8) # 17 20.1 (13.2, 29.4)
Utilities 125 5 4.6 (1.4, 14.5) # 5 4.2 (1.5, 11.2)#
Construction 1,235 52 5.4 (3.8, 7.6) 180 14.6 (12.2, 17.4)
Manufacturing: durable goods 1,063 29 3.5 (2.1, 5.7) 82 8.1 (6.1, 10.7)
Manufacturing: non-durable goods 750 23 3.7 (2.3, 5.9) 56 9.8 (7.2, 13.2)
Wholesale trade 461 17 4.6 (2.5, 8.1) 51 11.8 (8.7, 15.8)
Retail trade 1,733 68 5.1 (3.7, 7.1) 187 9.2 (7.5, 11.2)
Transportation and warehousing 688 36 4.9 (3.0, 7.9) 57 10.0 (7.4, 13.3)
Information 384 14 3.3 (1.6, 6.7) # 49 13.0 (9.4, 17.6)
Finance and insurance 610 18 3.2 (1.8, 5.5) 47 8.3 (5.6, 12.2)
Real estate and rental & leasing 347 16 5.4 (2.8, 10.3) 51 17.7 (12.0, 25.2)
Professional, scientific, and technical services 878 21 2.9 (1.7, 4.7) 62 7.9 (6.0, 10.2)
Administrative, waste management services 853 29 3.1 (2.0, 4.8) 107 13.2 (10.5, 16.5)
Educational services 1,294 36 2.2 (1.5, 3.2) 71 5.5 (4.0, 7.6)
Health care and social assistance 2,204 103 5.8 (4.6, 7.3) 121 5.4 (4.2, 6.9)
Arts, entertainment, and recreation 358 14 4.3 (2.2, 8.3) 53 17.2 (11.7, 24.6)
Accommodation and food services 1,332 54 6.4 (4.1, 9.7) 220 15.5 (12.2, 19.5)
Other services (except public administration) 800 35 4.3 (2.9, 6.5) 83 12.1 (9.1, 16.0)
Private households 200 6 4.3 (1.8, 10.2)# 6 6.1 (2.6, 13.7)
Public administration 666 27 4.0 (2.7, 5.9) 28 4.0 (2.7, 5.9) #
1

Prevalence estimates were age adjusted to the 2010 U.S. workers standard population by Bureau of Labor Statistics, using five age groups: 18–34, 35–44, 45–54, 55–64, 65+ years.

2

Marijuana, hashish, cocaine, heroin, methamphetamine, and needle injections drugs (cocaine, heroin, methamphetamine, steroids, and any other drugs).

#

The estimate of prevalence is unreliable because the relative standard error of the estimate is larger than 30%.

Table 4.

Age-adjusted prevalence1 of prescription opioids and illicit drug use among US adult workers, by occupational groups: 2005–2014

Rx opioid use
Illicit drug use2
Sample No. of Rx opioid Prev.1 (95%CI) No. of illicit drug Prev.1 (95%CI)



All 16,421 615 4.4 (3.9, 4.9) 1,550 9.7 (9.0, 10.4)



Management 1,394 41 3.0 (2.2, 4.1) 103 7.7 (5.7, 9.8)
Business and financial operations 585 13 2.7 (1.4, 4.9) 43 8.1 (5.7, 11.5)
Computer and Mathematics 383 14 4.8 (2.5, 9.0) 27 6.4 (4.2, 9.6)
Architecture and Engineering 244 5 3.1 (1.2, 7.7) # 15 7.1 (3.8, 12.1)
Life, physical, and social science 183 6 2.9 (1.2, 6.8) # 9 5.7 (2.5, 12.1) #
Community and social services 263 12 5.5 (2.7, 10.8) # 14 5.5 (2.5, 9.9) #
Legal 149 6 5.8 (2.3, 13.6) # 7 6.4 (2.8, 14.0) #
Education, training, and library 770 148 2.5 (1.5, 4.1) 30 4.1 (2.6, 6.3)
Arts, design, entertainment, sports & media 298 11 3.3 (1.76, 6.4) 34 14.3 (9.1, 21.6)
Healthcare practitioners and technicians 701 29 5.9 (3.8, 9.0) 24 4.2 (2.8, 6.3)
Healthcare support 518 26 5.0 (2.9, 8.8) 48 8.7 (5.8, 12.8)
Protective service 369 15 5.5 (2.9, 10.3) 25 6.4 (3.9, 10.2)
Food preparation and serving related 1,075 50 5.7 (3.6, 8.9) 181 15.8 (12.5, 19.7)
Building and grounds cleaning and maintenance 1,011 29 3.8 (2.5, 5.9) 81 10.8 (8.4 13.9)
Personal care and service 654 31 6.5 (4.1, 10.4) 66 10.4 (7.3, 14.5)
Sales and related 1,649 58 3.9 (2.8, 5.2) 188 10.7 (8.9, 12.7)
Office and administrative support 1,923 93 5.4 (4.2, 7.0) 162 8.5 (7.1, 10.2)
Farming, fishing, and forestry 132 2 1.7 (0.4, 6.7) # 6 6.4 (2.3, 16.6) #
Construction and extraction 1,102 46 4.8 (3.4, 6.8) 177 18.0 (15.1, 21.3)
Installation, maintenance, and repair 509 24 5.0 (3.2, 7.6) 74 14.0 (11.0, 17.6)
Production 1,177 39 4.5 (2.7, 7.2) 95 9.8 (7.6, 12.6)
Transportation and material moving 1,242 44 4.5 (3.1, 6.4) 133 11.2 (9.6, 13.1)
1

Prevalence estimates were age adjusted to the 2010 U.S. workers standard population by Bureau of Labor Statistics, using five age groups: 18–34, 35–44, 45–54, 55–64, 65+ years.

2

Marijuana, hashish, cocaine, heroin, methamphetamine, and needle injections drugs (cocaine, heroin, methamphetamine, steroids, and any other drugs).

#

The estimate of prevalence is unreliable because the relative standard error of the estimate is larger than 30%.

RESULTS

Prescription Opioid Use and Illicit Drug Use Among U.S. Adults by Type of Employment, 2005–2016

During the period 2005 to 2016, the prevalence of recent prescription opioid use (past 30 days) among all U.S. adults was 6.5% (6.0 to 7.0) (Table 1). The prevalence of recent use ranged from 3.4% (2.5 to 4.7) for the self-employed to 4.9% for the unemployed (3.3 to 7.1) and for retirees (3.5 to 7.0), while the prevalence for those not in the labor force was 14.4% (13.1 to 15.8). Among all adults taking prescription opioids, 63.4% (61.1 to 65.6) reported long-term use (>90 days). The highest proportion with long-term use was reported by the unemployed (76.8%; 67.4 to 84.0). The prevalence of illicit drug use in U.S. adults was 9.5% (8.8 to 10.1) overall, with a prevalence of 16.2% (14.2 to 18.5) among unemployed adults.

Prescription Opioid Use and Illicit Drug Use Among all U.S. Workers, 2005 to 2016

During 2005 to 2016, the prevalence of prescription opioid use among U.S. workers was 4.1% (3.7 to 4.5) overall (Table 2). Some groups of workers with high prevalence were current (6.3%; 5.4 to 7.3) or former (5.4%; 4.3 to 6.8) smokers and those with some college education (5.0%; 4.3 to 5.7). Among workers taking prescription opioids, 54.3% (50.5 to 58.1) reported long-term use. Workers with a high proportion of long-term use included those aged 45 to 59 (70.1%; 62.1 to 77.0), those who reported no alcohol consumption (62.9%; 55.2 to 70.0), and current smokers (62.2%; 53.1 to 70.6).

The prevalence of illicit drug use in workers was 10.2% (9.4 to 11.1). Groups with high prevalence were heavy drinkers (26.5%; 23.4 to 29.9), current smokers (22.6%; 20.7 to 24.5), and those aged 18 to 29 (19.0%; 9.4 to 11.1).

Prescription Opioid Use and Illicit Drug Use Among U.S. Workers by Industry, 2005 to 2014

Among the 21 NAICS industry groups included in this study, the prevalence of prescription opioid use during 2005 to 2014 was 4.4% (3.9 to 4.9) overall and ranged from 2.2% (1.5 to 3.2) in educational services to 7.4% (2.9 to 17.8) in mining (although the estimate for mining should be interpreted with caution due to a large RSE) (Table 3). Other industries with high prevalence of prescription opioid use were accommodation and food services (6.4%; 4.1 to 9.7), health care and social assistance (5.8%; 4.6 to 7.3), construction (5.4%; 3.8 to 7.6), and real estate and rental and leasing (5.4%; 2.8 to 10.3). The prevalence of illicit drug use was 9.7% (9.0 to 10.4) overall and ranged from 3.8% (1.6 to 8.4) in agriculture, forestry, fishing, and hunting to 20.1% (13.2 to 29.4) in mining. Other industries with high prevalence of illicit drug use were real estate and rental and leasing (17.7%; 12.0 to 25.2), arts, entertainment, and recreation (17.2%; 11.7 to 24.6), and accommodation and food services (15.5%; 12.2 to 19.5).

Prescription Opioid Use and Illicit Drug Use Among Workers by Occupation, 2005 to 2014

Across the 22 SOC occupational groups included in this study, the prevalence of prescription opioid use was 4.4% (3.9 to 4.9) and ranged from 1.7% (0.4 to 6.7) in farming, fishing, and forestry (estimate should be interpreted with caution due to a large RSE) to 6.5% (4.1 to 10.4) in personal care and service (Table 4). Other occupations with high prevalence of prescription opioid use were health care practitioners and technicians (5.9%; 3.8 to 9.0), legal (5.8%; 2.3 to 13.6, although this estimate should be interpreted with caution due to a large RSE), food preparation and serving related (5.7%; 3.6 to 8.9), protective service (5.5%; 2.9 to 10.3), and community and social service (5.5%; 2.7 to 10.8, although this estimate should be interpreted with caution due to a large RSE). The prevalence of illicit drug use was 9.7% (9.0 to 10.4) and ranged from 4.1% (2.6 to 6.3) in education, training, and library to 18.0% (15.1 to 21.3) in construction and extraction. Other occupations with high prevalence of illicit drug use were food preparation and serving related (15.8%; 12.5 to 19.7), arts, design, entertainment, sports, and media (14.3%; 9.1 to 21.6), and installation, maintenance, and repair (14.0%; 11.0 to 17.6).

DISCUSSION

This study examined prescription opioid use and illicit use of other drugs by worker characteristics, industry, and occupation using National Health and Nutrition Examination Survey (NHANES) data, 2005 to 2016. The prevalence of prescription opioid use was higher among those not working (unemployed, retired, not in the labor force) than among workers (private companies, government, self-employed). The prevalence of illicit drug use was higher among the unemployed than among workers. A variety of demographic, lifestyle, and socioeconomic characteristics were observed with higher prevalence of prescription opioid use and illicit drug use among workers. The prevalence of prescription opioid use ranged from 2.2% to 7.4% across 21 industries and from 1.7% to 6.4% across 22 occupational groups. The prevalence of illicit drug use ranged from 3.8% to 20.1% across the same industries and from 4.1% to 18.0% across occupational groups.

In the present study, the prevalence of recent prescription opioid use was highest among those not in the labor force (14.4%); unemployed workers had the highest proportion of long-term use of prescription opioids. In a previous study that focused specifically on past-year nonmedical use of prescription opioids (not prescribed for the respondent or use only for the experience or feeling) using data from the National Survey on Drug Use and Health (NSDUH), 2011 to 2013, the highest prevalence for nonmedical use of prescription opioids was among the unemployed, three times greater than for those not in the labor force.14 Unemployment has also been associated with current opioid use disorder (a DSM-5 diagnosis that excludes those under appropriate medical supervision) in the 2012 to 2013 National Epidemiological Survey on Alcohol and Related Conditions III (NESARC III).15 In the present study, the highest prevalence of illicit drug use (16.2%) was among the unemployed, similar to the prevalence of 18.2% for past-month illicit drug use among the unemployed in the 2013 NSDUH.16

Our findings are consistent with findings in the study by Asfaw et al using the Medical Expenditure Panel Survey, that showed the prevalence of prescription opioid purchases was highest among ages 45 years and older.12 There are relatively few other published papers that look at the prevalence of current prescription opioid use or illicit drug use among U.S. workers. This demonstrates the need for additional research in this area.

Long-term use of prescription opioids for chronic pain has been shown to be associated with opioid use disorder and overdose deaths.8,1719 The epidemic of opioid overdose began with deaths due to use of prescription opioids for chronic pain (in the 1990s), followed by a predominance of heroin overdoses (in 2010), then synthetic opioids such as fentanyl (in 2013).20 Wilson and colleagues reported that during 2017 to 2018, 68% of drug overdose deaths in the U.S. involved an opioid,21 and a quarter of patients who received long-term opioid therapy in a primary care setting struggled with opioid use disorder.22,23 Our finding of the proportion of long-term use of prescription opioids may indicate increasing risk for substance use disorder, especially in workers who were 45 or more years of age, those who took heavy alcohol, or current smokers.

In previous studies, the prevalence of prescription opioid use and opioid-related overdose deaths were highest among workers in construction and agriculture and fishing industries.3,79 However, in the current study, workers in accommodation and food services had the highest prevalence of prescription opioid use (6.4%), followed by those in health care and social assistance (5.8%) and construction (5.4%). Prescription opioid use in these three industry sectors represents a third of opioid use across the 21 industry sectors. In a recent study, the Montana Department of Labor and Industry showed that workers in restaurants had the most opioid claims for their injuries.24

Workers who may more easily access prescription opioids, such as healthcare practitioners and technicians (5.9%), had higher prevalence of prescription opioid use than the overall prevalence of all occupations (4.4%). These workers may benefit from public health programs with a focus on treating prescription opioid use disorder, but that also include essential response strategies such as medication-assisted treatment and increased availability of naloxone to treat opioid overdose.25 NIOSH recently released a workplace solutions document “Medication-Assisted Treatment for Opioid Use Disorder,” which provides information for workers and employers on preventing opioid use disorder and facilitating support treatment if it does occur.26

Among industry groups, workers in mining had the highest prevalence of illicit drug use which is two times higher than the average prevalence for all industry groups (20.1% and 9.7%, respectively). A 2015 report from the Substance Abuse and Mental Health Service Administration revealed that 5% of mining workers reported illicit drug use within the past month.25 Workers in Arts, entertainment, and recreation (17.2%) and accommodation and food services (15.5%) had high prevalence of illicit drug use. A report using 2008 to 2012 data from NSDUH had similar results for fulltime workers in these two industry areas (19.1% and 13.7%, respectively).25 Among occupational groups, workers in construction and extraction had the highest prevalence of illicit drug use. No other studies on the prevalence of illicit drug use by occupations were identified.

Limitations and Strengths

There are a few limitations that must be taken into consideration. First, the estimated prevalence of prescription opioid use and illicit drug use in this study was based entirely on self-reported survey responses. Although the self-reported prescription opioid use was verified by an interviewer, illicit drug use was collected through an Audio Computer-Assisted Self-Interview system and might have been subject to recall and response bias. Second, although information on illicit drug use was collected among participants who were 12 years and older, the data on illicit drug use that was made available to the public during 2005 to 2008 consisted only of participants ages 20 years and older. However, we did not restrict our analyses to this group (20+ years) but also included persons 18 years and older. Therefore, lack of information on illicit drug use among those who were 18 to 19 years old during the survey cycles of 2005 to 2006 and 2007 to 2008 might have resulted in an underestimation of the prevalence of illicit drug use, particularly among industries or occupations that have a larger percentage of young workers. In addition, the data did not have diagnostic information, therefore, prescription opioid misuse could not be estimated. Another limitation is that the prevalence of prescription opioid use by specific type of drug could not be estimated due to the small subsample size among U.S. workers. The illicit drug use variable is based on questions that did not specifically ask about opioids, and it is unclear how much of the reported illicit drug use is opioid-related. Cautions need to be taken when interpreting the results. Although NHANES includes detailed information on occupation and drug use, the sample sizes for some specific occupation and industry groups were small which resulted in unreliable estimates with large variance.

However, there are also a few strengths to this study. The data are based on a nationally representative sample and provide the opportunity to estimate the prevalence of prescription opioid use and illicit drug use by industry and occupation among all workers. In addition, the data collected include a variety of work characteristics and sociodemographic variables which allowed us to evaluate how these factors are associated with prescription opioid use and illicit drug use among the working population.

CONCLUSION

The results of our study show that the prevalence of prescription opioid use in the past 30 days was 6.5% among all U.S. adults. Unemployed persons reported the highest prevalence of long-term prescription opioid use and the highest prevalence of illicit drug use.

Among employed workers, those employed in the mining industry reported the highest prevalence of both prescription opioid use and illicit drug use. Workers in personal care and service occupations reported the highest prevalence of prescription opioid use, while those in construction and extraction occupations reported the highest prevalence of illicit drug use.

Our findings underscore the need for education and intervention among all workers but especially those in the industries and occupations most affected by prescription opioid use and illicit drug use. The prevalence of prescription opioid use among some occupational groups compared to the overall prevalence suggests that these groups may be experiencing more injuries and pain. For these groups, it is important to prescribe opioids only when the benefits exceed the risks. However, prescriptions are only short-term solutions and studies should be conducted to identify the most effective interventions that can be implemented to decrease the prevalence of the injuries or other sources of pain. The prevalence of illicit drug use among certain occupational groups suggests the need to ensure access to substance use treatment provision when needed.

Supplementary Material

supplemental figure

Acknowledgments

This work was supported by the National Institute for Occupational Safety and Health (NIOSH).

Footnotes

The authors report no conflicts of interest.

Disclaimer: The findings and conclusions in this report are those of the authors and do not necessarily represent the official position of the National Institute for Occupational Safety and Health, Centers for Disease Control and Prevention. This manuscript reflects the views of the author and should not be construed to represent FDA’s views or policies.

Clinical significance: Our study found that prevalence of prescription opioid use was 6.5% (adults) and 4.1% (adult workers) and the prevalence of illicit drug use was 9.5% (adults) and 10.2% (adult workers) during 2005 to 2016. Among occupational groups, prevalence of prescription opioid use ranged from 1.7% (farming/fishing/forestry) to 6.5% (personal care) and for illicit drug, 4.1% (education/training/library) to 18.0% (construction/extraction).

Supplemental digital contents are available for this article. Direct URL citation appears in the printed text and is provided in the HTML and PDF versions of this article on the journal’s Web site (www.joem.org).

Contributor Information

Ja K. Gu, Bioanalytics Branch, Health Effects Laboratory Division, National Institute for Occupational Safety and Health, Centers for Disease Control and Prevention, Morgantown, West Virginia.

Penelope Allison, Bioanalytics Branch, Health Effects Laboratory Division, National Institute for Occupational Safety and Health, Centers for Disease Control and Prevention, Morgantown, West Virginia.

Alexis Grimes Trotter, Health Informatics Branch, Division of Field Studies and Engineering, National Institute for Occupational Safety and Health, Centers for Disease Control and Prevention, Cincinnati, Ohio; Division of Environmental Health Sciences, Midwest Center for Occupational Health and Safety Education and Research Center, School of Public Health, University of Minnesota, Minneapolis, Minnesota.

Luenda E. Charles, Bioanalytics Branch, Health Effects Laboratory Division, National Institute for Occupational Safety and Health, Centers for Disease Control and Prevention, Morgantown, West Virginia.

Claudia C. Ma, Center for Tobacco Products, Office of Science, Food and Drug Administration, Beltsville, Maryland; Former Affiliate of Bioanalytics Branch, Health Effects Laboratory Division, National Institute for Occupational Safety and Health, Morgantown, West Virginia.

Matthew Groenewold, Health Informatics Branch, Division of Field Studies and Engineering, National Institute for Occupational Safety and Health, Centers for Disease Control and Prevention, Cincinnati, Ohio.

Michael E. Andrew, Bioanalytics Branch, Health Effects Laboratory Division, National Institute for Occupational Safety and Health, Centers for Disease Control and Prevention, Morgantown, West Virginia.

Sara E. Luckhaupt, Health Informatics Branch, Division of Field Studies and Engineering, National Institute for Occupational Safety and Health, Centers for Disease Control and Prevention, Cincinnati, Ohio.

REFERENCES

Associated Data

This section collects any data citations, data availability statements, or supplementary materials included in this article.

Supplementary Materials

supplemental figure

RESOURCES